Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling

This publication has 17 references indexed in Scilit:

• Development of a physiologically based pharmacokinetic model for chloroform
  Toxicology and Applied Pharmacology, 1990
• Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesis
  Toxicology Letters, 1988
• Physiologically based pharmacokinetics and the risk assessment process for methylene chloride
  Toxicology and Applied Pharmacology, 1987
• Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice
  Fundamental and Applied Toxicology, 1985
• Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsomal enzyme inhibitor piperonyl butoxide
  Toxicology and Applied Pharmacology, 1981
• Mutation and Cancer: A Model for Human Carcinogenesis2
  JNCI Journal of the National Cancer Institute, 1981
• Polybrominated biphenyl-induced potentiation of chloroform toxicity
  Toxicology and Applied Pharmacology, 1978
• Phosgene: A metabolite of chloroform
  Biochemical and Biophysical Research Communications, 1977
• Mechanisms of Acute Hepatic Toxicity
  Anesthesiology, 1974
• Chloroform toxicity in mice: Correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules
  Experimental and Molecular Pathology, 1973